@incollection{,
	
					
					
					72524C4706E3D9A19F744750A4F7E56F
				,
	author={{Ms. KiranKumari} and {Dr. AjaySharma}},
	journal={{Global Journal of Medical Research}},
	journal={{GJMR}}2249-46180975-588810.34257/GJMR,
	address={Cambridge, United States},
	publisher={Global Journals Organisation}1911724
}

@book{b0,
	
	
		,
	title={{Novartis Fights India for Cancer Pill Patent. The Wall street Journal}}
		,
	author={{
			RummanAhmed
		} and {
			AmolSharma
		}}
		
		
		
			,
	year={2012}
		
	

}

@incollection{b1,
	
	
		,
	title={{The conflicts between parallel trade and product access and innovation: The case of pharmaceuticals}}
		,
	author={{
			HEBale
		}}
		
	
	
		,
	journal={{Journal of Internationa. Economic Law}}
		
			1
			4
			
			,
	year={1998}
		
	

}

@incollection{b2,
	
	
		,
	title={{Legal Factors in TRIPs}}
		,
	author={{
			NilimaChandiramani
		}}
	
	
		,
	journal={{Economic and Political Weekly. Centre for Civil Society}}
		
			8
			,
	year={2002}
		
	

}

@incollection{b3,
	
	
		,
	title={{Current Scenario of Patent Act: Compulsory Licensing}}
		,
	author={{
			HChander
		} and {
			VChoudhary
		} and {
			VKumar
		}}
		
		
		10.5530/ijper.47.3.5
		
	
	
		,
	journal={{Indian Journal of Pharmaceutical Education and Research}}
		
			47
			3
			27
			,
	year={2013}
		
	

}

@book{b4,
	
	
		,
	title={{Gray Markets, Forbes India}}
		,
	author={{
			KChristensen
		}}
		
		
			,
	year={2012. December 2018}
			12
		
	

}

@book{b5,
	
	
		,
	title={{Empirical and Mathematical Reasoning: The Business and Politics of Health}}
		,
	author={{
			DavidMCutler
		}}
		
			,
	year={2017}
			,
	address={Harvard University}
		
	

}

@incollection{b6,
	
	
		,
	title={{compulsory licensing and access to medicines in post Doha Era: what hope for Africa?}}
		,
	author={{
			E
		} and {
			Durojaye
		}}
		
	
	
		,
	journal={{Journal of Intellectual Property Law}}
		
			18
			2
			35
			,
	year={2011}
		
	

}

@incollection{b7,
	
	
		,
	title={{Compulsory Licensing under TRIPS: How afar it Addresses Public Health Concerns in Developing Nations}}
		,
	author={{
			RGupta
		}}
	
	
		,
	journal={{Journal of Intellectual Property Rights}}
		
			15
			
			,
	year={2010}
		
	

}

@incollection{b8,
	
	
		,
	title={{Compulsory licenses under trips and its obligations for member countries}}
		,
	author={{
			TJain
		}}
	
	
		,
	journal={{ICFAI Journal of Intellectual Property Rights}}
		
			8
			1
			,
	year={2009}
		
	

}

@incollection{b9,
	
	
		,
	title={{Compulsory Licensing of Drugs and Pharmaceuticals: Issues and Dilemma}}
		,
	author={{
			AKaur
		} and {
			RChaturvedi
		}}
		
		
	
	
		,
	journal={{Journal of Intellectual Property Rights}}
		
			20
			
			,
	year={2015}
		
	

}

@incollection{b10,
	
	
		,
	title={{Novartis loses landmark India cancer drug patent case}}
		,
	author={{
			KKulkarni
		} and {
			SMohanti
		}}
		
		
	
	
		,
	journal={{Business News Reuters}}
		
			,
	year={2013}
		
	

}

@incollection{b11,
	
	
		,
	title={{Novartis Loses Historic India Patent Case on Cancer Drug Glivec}}
		,
	author={{
			SKumar
		}}
		
	
	
		,
	journal={{Asian Scientist. Retrieved}}
		
			,
	year={2013}
		
	

}

@incollection{b12,
	
	
		,
	title={{Compulsory Licensing of Pharmaceutical Patents in India: A Research Study}}
		,
	author={{
			VMathur
		} and {
			BPNagori
		} and {
			MTiwari
		}}
		
		
	
	
		,
	journal={{European Journal of Pharmaceutical and Medical Research}}
		
			3
			3
			
			,
	year={2016}
		
	

}

@incollection{b13,
	
	
		,
	title={{Lee Pharma Limited vs}}
		,
	author={{
			MadrasHigh
		} and {
			CourtJudgement
		}}
		
		
	
	
		,
	journal={{Lee Pharmaceuticals on}}
		
			,
	year={8 May, 2017}
		
	

}

@book{b14,
	
	
		,
	author={{
			PNarayanan
		}}
		,
	title={{Patent Law}}
				
			,
	publisher={Eastern Law House}
			,
	year={1998}
			4
		
	
	,
	note={third edition}

}

@book{b15,
	
	
		,
	title={{Report on the Revision of the Patent Law}}
		,
	author={{
			RAyyangar
		}}
		
			,
	year={1959}
			,
	address={New Delhi}
		
	

}

@book{b16,
	
	
		,
	title={{}}
		,
	author={{
			SSRana
		}}
		
		
			,
	year={November 26. 2018}
		
	

}

@book{b17,
	
	
		,
	title={{Declaration on the TRIPS Agreement and Public Health}}
		,
	author={{
			LTaylor
		}}
		
		
			,
	year={2013. 2001}
		
	
	,
	note={World Trade Organization Ministerial Conference}

}

@book{b18,
	
	
		,
	title={{}}
		,
	author={{
			PharmatutorAnoverview
		}}
		
		
			,
	year={December 2018}
			3
			13
		
	

}

@incollection{b19,
	
	
		,
	title={{Compulsory licensing: For better or for worse, the done deal lies in the balance}}
		,
	author={{
			DYang
		}}
	
	
		,
	journal={{Journal of Intellectual Property Rights}}
		
			17
			
			,
	year={2012}
		
	

}

@book{b20,
	
	
		,
	title={{Doha Declaration: Compulsory Licensing and Access to Drugs}}
		
	

}